Reuters logo
BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 Q1 net profit to increase by 220 pct to 250 pct
April 7, 2017 / 2:36 AM / 5 months ago

BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 Q1 net profit to increase by 220 pct to 250 pct

April 7(Reuters) - Shanxi Zhendong Pharmaceutical Co Ltd :

* Says net profit for FY 2017 Q1 to increase by 220 percent to 250 percent, or to be 55.3 million yuan to 60.5 million yuan, compared to net profit of FY 2016 Q1 (17.3 million yuan)

* Says increased revenue as main reason for the forecast

Source text in Chinese: goo.gl/hTvSKk

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below